No Data
Ribomic --- Shares Rise After Signing Joint Research Agreement with SK Plasma on Aptamer-Drug Conjugates
An upward trend. Following the announcement after the close of trading on the 16th regarding the conclusion of a joint research agreement with SK Plasma on aptamer-drug complexes, the news has been viewed as positive. Through this collaborative research, the two companies aim to create a complex combining SK Plasma's drug under development with their aptamer, working towards the development of compounds with promising new characteristics. The research will leverage insights from both companies’ R&D expertise to advance studies in this field. In connection with the signing of this agreement, SK Plasma will provide Ribomic with...
RiboMics has been ranked and entered into a joint research agreement with South Korea's SK Pharmatech.
Ribomic <4591> has ranked among the top (as of 9:35 AM). The stock is rising following an announcement after the close of trading yesterday that the company has entered into a joint research agreement with South Korea’s SK Pharma to develop aptamer-drug conjugates, which appears to be driving buying interest. By combining SK Pharma’s drug under development with Ribomic’s aptamer technology, the collaboration aims to create compounds with promising new characteristics. [As of April 17, 09:35, based on the volume change rate relative to the five-day average trading volume.]
Weak sentiment prevails, with profit-taking likely dominating in the emerging markets individual stock strategy.
[Emerging Market Stock Strategy] Today's emerging market is expected to remain subdued. In the U.S. stock market on the 16th, the Dow Jones Industrial Average rebounded, rising 115.00 points (+0.24%) to close at 48,578.72. Rising crude oil prices and interest rates due to the continued blockade of the Strait of Hormuz weighed on stock prices; however, better-than-expected economic indicators supported the market. Additionally, investor sentiment was buoyed by former President Trump’s announcement that Israel and Lebanon had agreed to a 10-day ceasefire. Today’s emerging...
DELTA-P, Nissou, and others
<1444> Nisso acquired shares of Daiichi Giken, a company specializing in large-scale renovation projects, making it a subsidiary. <4450> PSOL revised and expanded its shareholder benefits program. The company also acquired shares of Azest, which is engaged in business intelligence services, making it a subsidiary. <4564> OTS witnessed the mass exercise of the 38th series of share warrants with an exercise price adjustment clause, resulting in the issuance of 15 million shares starting from the 10th. <4591> Ribomic entered into a joint research agreement with SK Plasma (South Korea). <4598> DELTA-P.
Morpho, NetEase, and others
Storage King (2997) has acquired real estate for sale (land in Setagaya-ku and Ota-ku, Tokyo). Genepa (3195) has obtained a manufacturing and sales license for Class III medical devices. Ekitan (3646) has been approved for a market category change to the Tokyo Stock Exchange Standard Market. Morpho (3653) has announced a share buyback program with an upper limit of 140,000 shares (2.67% of issued shares), which will be purchased on the 1st through ToSTNeT-3. The capital and business alliance with Denso (6902) has been dissolved following the expiration of the technology partnership agreement. NetYear (3622)...
Cautious sentiment continues amid ongoing concerns over the situation in the Middle East.
[Emerging Market Stock Strategy] The emerging market is expected to trade lower today. In the U.S. stock market on the 26th, the Dow Jones Industrial Average fell by 469.38 points (-1.01%) to close at 45,960.11, reversing previous gains. Reports that Iran rejected a proposal from the Trump administration, along with President Trump’s remarks during a cabinet meeting, heightened concerns over escalating attacks against Iran, weighing on stock prices. Rising interest rates also led to the sell-off of technology stocks. The emerging market today is likely to see selling pressure dominate. Following yesterday's overseas market movements,